Smart drug data solutions for health plans and pharmacy benefit managers

The sheer amount of data required to support healthcare business and medication safety decisions is impossible for one person, or even one organization, to wrangle. Medi-Span drug data from Wolters Kluwer streamlines valuable content and decision support functionality into robust and intelligent databases and integrated tools that can be used throughout your organization to educate, alert, and support faster, better-informed decision-making.

Drug data solutions at work every day

PBMs and health plans use Medi-Span content for drug descriptive data, therapeutic classification systems, drug pricing data… the basic backbones of their systems. Depending on your goals and business needs, here are some ways Medi-Span can help you:

Business woman presenting on a laptop to a male colleague in a conference room
Whitepaper
Balancing volume and precision

 

Decision consistency is essential for payer care management, drug management, and medical benefits teams. Payer organizations need to apply trusted evidence and data standards across different teams to help them improve efficiency and scale without losing defensibility of decisions and clinical nuance.
Download The Whitepaper

Wolters Kluwer drug data solutions are trusted in the market

17 out of 20 of the top-grossing PBMs and 95% of the 20 top health plans use our drug data to adjudicate claims, maintain their formularies, and access their member population.
Businesswoman and man working together with laptops near the window at the office
Navigating complexity with certainty
Aligned data and trusted evidence can empower payer teams to build proactive strategies and unite stakeholders to tackle current industry challenges, such as operational inefficiencies caused by siloed teams and balancing cost and compliance with quality care.
Download The eBook
Prescription medicine pill bottle and pills.
Polypharmacy: Are your members at risk?
Health plans have relied on Medi-Span drug data for 50+ years to manage claims, formularies, and safety. With 67% of seniors on 5+ meds, payers can reduce adverse drug events by leveraging full med histories. Download our whitepaper to learn more.
Download The Whitepaper
Diverse group of businesspeople laughing together during an office meeting
Aligning drug decision-making between PBMs and health plans
To keep patients and members safe without sacrificing efficiency or profit, healthcare businesses need consistent drug data to help align decision-making and communication between players including pharmacy benefit managers, payers, physicians, and pharmacies.
Access The eBook
  • Provides confidence
Even in an era where data abounds, there is a terrific amount of uncertainty. People want confidence that what they are seeing is [based on] real [manufacturer-provided information]—Medi-Span provides that confidence.
Health plan executive

Download the whitepaper

Please fill out the form for your copy of the whitepaper, Balancing volume and precision in payer decision-making:

  • How decision consistency impacts payer performance.
  • The value of data and analytics governance in supporting consistent, scalable decisions.
  • Bringing drug and clinical intelligence into payer workflows to support decision consistency without losing nuance.
Back To Top